Citadel Advisors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.26M | Buy |
|
|||||
|
2025
Q1 | $2.14M | Sell |
|
|||||
|
2024
Q4 | $12.5M | Sell |
|
|||||
|
2024
Q3 | $14.4M | Sell |
|
|||||
|
2024
Q2 | $42.3M | Sell |
|
|||||
|
2024
Q1 | $49.6M | Buy |
|
|||||
|
2023
Q4 | $28.3M | Sell |
|
|||||
|
2023
Q3 | $15.9M | Buy |
|
|||||
|
2023
Q2 | $20.7M | Sell |
|
|||||
|
2023
Q1 | $18.5M | Sell |
|
|||||
|
2022
Q4 | $25.4M | Buy |
|
|||||
|
2022
Q3 | $27.2M | Buy |
|
|||||
|
2022
Q2 | $20.2M | Sell |
|
|||||
|
2022
Q1 | $25.6M | Buy |
|
|||||
|
2021
Q4 | $37.6M | Buy |
|
|||||
|
2021
Q3 | $40.3M | Sell |
|
|||||
|
2021
Q2 | $51.2M | Buy |
|
|||||
|
2021
Q1 | $77.4M | Buy |
|